Clinical trial
A Randomized Phase IIa, Multi-center, Double-blind, Placebo-controlled Study to Assess the Safety, Feasibility, Tolerability, and Efficacy of a New Buccal Film of Montelukast in Patients With Mild to Moderate Alzheimer's Disease
NCT03402503 is registered in ClinicalTrials.gov with IntelGenx Corp. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Phase IIa, Multi-center, Double-blind, Placebo-controlled Study to Assess the Safety, Feasibility, Tolerability, and Efficacy of a New Buccal Film of Montelukast in Patients With Mild to Moderate Alzheimer's Disease
- Lead sponsor
- IntelGenx Corp.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 26, 2018
- Completion date
- April 3, 2024
- Enrollment
- 52 (actual)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.